A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA)

Clinical trial NCT04115189 · COMPLETED

Trial details

NCT number: NCT04115189
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Renal Cell Carcinoma ( mRCC)

Start date: 2019-12-13
Primary completion: 2020-12-02
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.